Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China.
State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China.
Am J Chin Med. 2022;50(3):817-838. doi: 10.1142/S0192415X22500343. Epub 2022 Mar 10.
Dysbiotic gut microbiota has been identified as a primary mediator of inherent inflammation that underlies the pathogenesis of obesity. Cordyceps comprises the larval body and the stroma of (BerK.) Sacc. parasiting on larvae of moths () with potent metabolic regulation functions. The underlying anti-obesity mechanisms, however, remain largely unknown. Here, we demonstrate that the water extract of Cordyceps attenuates glucose and lipid metabolism disorders and its associated inflammation in high-fat diet (HFD)-fed mice. 16S rRNA gene sequencing and microbiomic analysis showed that Cordyceps reduced the amounts of , a bile-salt hydrolase-producing microbe to regulate the metabolism of bile acids in the gut. Importantly, transplantation or liver-specific knockdown of farnesoid X receptor (FXR), a bile acid receptor, diminished the protective effect of Cordyceps against HFD-induced obesity. Together, our results shed light on the mechanisms that underlie the glucose- and lipid-lowering effects of Cordyceps and suggest that targeting intestinal or hepatic FXR are potential anti-obesity and anti-inflammation therapeutic avenues.
肠道菌群失调已被确定为肥胖发病机制中固有炎症的主要介质。冬虫夏草包括幼虫体和寄生于鳞翅目幼虫()上的(BerK.)Sacc. 的基质,具有很强的代谢调节功能。然而,其潜在的抗肥胖机制在很大程度上尚不清楚。在这里,我们证明了冬虫夏草水提物可减轻高脂肪饮食(HFD)喂养小鼠的葡萄糖和脂质代谢紊乱及其相关炎症。16S rRNA 基因测序和微生物组分析表明,冬虫夏草减少了产生胆盐水解酶的微生物的数量,从而调节肠道中胆汁酸的代谢。重要的是,移植或肝脏特异性敲低法尼醇 X 受体(FXR),一种胆汁酸受体,可减弱冬虫夏草对 HFD 诱导肥胖的保护作用。总之,我们的研究结果阐明了冬虫夏草降低血糖和血脂的作用机制,并表明靶向肠道或肝脏 FXR 可能是一种潜在的抗肥胖和抗炎治疗方法。